Symptomatic Care in Multiple System Atrophy: State of the Art.

"Declarations Conflict of InterestKS reports personal fees from Teva, UCB, Lundbeck, AOP Orphan Pharmaceuticals AG, Roche, Gruenenthal, Stada, Lucher Pharma, Biogen, BIAL, and AbbVie, and honoraria from the International Parkinson and Movement Disorders Society. All other authors declare no competing interests. Conflict of Interest KS reports personal fees from Teva, UCB, Lundbeck, AOP Orphan Pharmaceuticals AG, Roche, Gruenenthal, Stada, Lucher Pharma, Biogen, BIAL, and AbbVie, and honoraria from the International Parkinson and Movement Disorders Society. All other authors declare no competing interests."

"Funding Open access funding provided by University of Innsbruck and Medical University of Innsbruck. KS received research grants from FWF Austrian Science fund, Michael J. Fox Foundation and AOP Orphan Pharmaceuticals AG."